2C73.01

ICD-11 MMS 2026-01

Endometrioid adenocarcinoma of ovary

Description

An endometrioid adenocarcinoma arising from the ovary. It comprises 10% to 25% of all primary ovarian carcinomas. Grossly, endometrioid carcinoma may present as a cystic or solid mass. Microscopically, the tumour greatly resembles the appearance of the ordinary type of endometrial adenocarcinoma. As a group, endometrioid carcinoma has a prognosis twice as good as that of serous or mucinous carcinoma.

Coding note from above levels

Includes Malignant neoplasm of skin of female genital organs

For use of this category, reference should be made to the mortality coding rules and guidelines in the Reference Guide.

Index terms

  • Endometrioid adenocarcinoma of ovary
  • endometroid carcinoma of ovary

Exclusions from above levels

  • 2E05.0 – Malignant neoplasm metastasis in ovary
  • http://id.who.int/icd/entity/1965082709 – Malignant mesenchymal neoplasms
  • 2E05 – Malignant neoplasm metastasis in female reproductive system
Show allHide
  • http://id.who.int/icd/entity/879154182 – Neoplasms of central nervous system or related structures
  • http://id.who.int/icd/entity/944754984 – Neoplasms of haematopoietic or lymphoid tissues

Sibling codes

  • 2C73.00 – Clear cell adenocarcinoma of ovary
  • 2C73.02 – Low grade serous adenocarcinoma of ovary
  • 2C73.03 – High grade serous adenocarcinoma of ovary
  • 2C73.04 – Mucinous adenocarcinoma of ovary
  • 2C73.0Y – Other specified carcinomas of ovary
  • 2C73.0Z – Carcinomas of ovary, unspecified

Foundation entity

Endometrioid adenocarcinoma of ovary – http://id.who.int/icd/entity/996484353

Allowed postcoordination axes

Part of: 2C73.0: Carcinomas of ovary › 2C73: Malignant neoplasms of ovary › 02: Neoplasms